OKUR — OnKure Therapeutics, Inc.

OKUROnKure Therapeutics, Inc.

NAS · US · Healthcare · Biotechnology · onkuretherapeutics.com

4.240USD+1.44%Mkt Cap: 170.47M USDP/E: —Last update: 2026-06-01

OnKure Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on the discovery and development of precision medicines that target biologically validated drivers of cancers and other diseases. Its lead pr…

Industry Peers

Biotechnology

VRTX

Vertex Pharmaceuticals Incorporated

Regeneron Pharmaceuticals, Inc.

Alnylam Pharmaceuticals, Inc.

40.10BUSDP/E 75.3

RVMD

Revolution Medicines, Inc.

Indicators:|

Key Statistics

Company

Market Cap170.47M USD

Enterprise Value-21.23M USD

Revenue (TTM)—

Gross Profit—

Net Income (TTM)-59.52M USD

Revenue/Share—

Last Price4.240 USD

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees45

CountryUS

SectorHealthcare

IndustryBiotechnology

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)-1.97

PEG—

EV/EBITDA0.35

EV/Revenue—

P/S—

P/B0.92

EPS (TTM)-4.32

EPS (Forward)-2.13

52W Range

1.91067% of range5.380

52W High5.380 USD

52W Low1.910 USD

Profitability

Gross Margin0.00%

Oper. Margin0.00%

EBITDA Margin0.00%

Profit Margin0.00%

ROE-105.93%

ROA-95.81%

Growth

Revenue Growth—

Earnings Growth—

Cash Flow & Leverage

Operating CF-51.83M USD

CapEx (TTM)46.00K USD

FCF Margin—

FCF Yield-14.20%

Net Debt-191.70M USD

Net Debt/EBITDA3.14

Balance Sheet

Debt/Equity0.01

Current Ratio13.78

Quick Ratio13.41

Book Value/Sh4.564 USD

Cash/Share4.756 USD

Dividends

Fwd Div Rate—

Trail. Div Rate0.0000 USD

Div. Yield—

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split1:10

Split DateOct 7, 2024

Analyst Consensus

Rating—

Target (Mean)20.20 USD

Target Range11.00 USD – 30.00 USD

# Analysts5

Ownership

Shares Out.40.40M

Float19.64M

Insiders10.48%

Institutions74.91%

Short Interest

Short Ratio1.5d

Short % Float0.55%

Short % Out.0.49%

Shares Short199.39K

Short (prev mo.)69.49K

Technical

SMA 504.250 (-0.2%)

SMA 2003.214 (+31.9%)

Beta—

S&P 52W Chg27.94%

Avg Vol (30d)149.67K

Avg Vol (10d)209.89K

Technical Indicators

RSI (14)53.7

MACD-0.0571

MACD Signal-0.1418

MACD Hist.+0.0847

BB Upper4.866 USD

BB Middle3.869 USD

BB Lower2.873 USD

BB Width51.51%

ATR (14)0.3202 USD

Vol Ratio (20d)0.38x